C. Boga et al. / Journal of Organometallic Chemistry 601 (2000) 233–236
235
Ref. [3]. The characteristics of compounds 1b, 1c, 2c,
3c, 4c are in agreement with literature data [7,10].
slowly added. After further 30 min, CBr4 (0.48 g, 1.48
mmol), dissolved in THF (2 ml), was added. The reac-
tion was monitored by TLC (eluant: 7:3 petroleum
light–diethyl ether) and GC–MS analyses, then it was
quenched with aqueous saturated solution of NH4Cl,
diluted with diethyl ether, and dried over anhydrous
Na2SO4. After filtration, evaporation of the solvent at
reduced pressure and FC (eluant: 7.5:2.5 light
petroleum–diethyl ether) of the residue, pure 6 (0.08 g,
27%) was obtained.
3.2. Reactions between 2-lithio heterocycles and
tetrahalogenomethanes: typical procedure
To a solution containing 2.5 mmol of 2-lithio-N-
methyl benzimidazole in 5 ml of THF, cooled at
−70°C, CCl4 (0.24 ml, 2.5 mmol) (diluted in 5 ml of
THF) was added. The solution turned immediately
dark and after 15 min, TLC (eluant: 7:3 light
petroleum–diethyl ether) and GC–MS analyses showed
85% conversion. After 15 min, the reaction was
quenched with a saturated aqueous solution of NH4Cl
(2 ml), diluted with diethyl ether and dried over anhy-
drous MgSO4. After filtration, the solvent was removed
at reduced pressure. FC (eluant: dichloromethane) of
the residue gave 0.315 g (76%) of 4c.
1H-NMR (CDCl3):
l
7.51 (s, 1H). 13C-NMR
(CDCl3): l 145.4, 142.8, 109.3. MS (m/e): 201 [M+],
199, 197, 120, 118.
3.3.6. 5-Bromo-2-chloro-N-methylimidazole (7)
compound 7 was obtained in 63% yield from 3c
following the procedure above described for the prepa-
ration of 6.
M.p. 92–94°C. 1H-NMR (CDCl3): l 6.92 (s, 1H),
3.59 (s, 3H, CH3). 13C-NMR (CDCl3): l 131.9, 128.1,
103.7, 32.2. MS (m/e): 198 [M+], 196, 194, 117, 115, 80.
3.3. Physical constants of compounds synthesized
3.3.1. 2-Bromobenzothiazole (2b)
M.p. 39–41°C (lit. [11]: 39.5–40°C). 1H-NMR
(CDCl3): l 7.98 (dd, 1H, J=7.5, J=1.5 Hz, 4-H or
7-H), 7.79 (dd, 1H, J=7.8, J=1.8 Hz, 4-H or 7-H),
7.50–7.35 (m, 2H, 5-H and 6-H). 13C-NMR (CDCl3): l
152.5, 139.0, 137.5, 126.8, 126.0, 123.0, 121.0. MS
(m/e): 215, 213, 134.
Acknowledgements
Investigation supported by University of Bologna
(funds for selected research topics AA. 1997–99), Min-
istero dell’Universita` e della Ricerca Scientifica e Tec-
nologica (MURST, Roma), Consiglio Nazionale delle
Ricerche (CNR, Roma).
3.3.2. 2-Bromo-N-methylimidazole (3b)
1H-NMR (CDCl3): l 6.85 (d, 1H, J=2.1 Hz), 6.72
(d, 1H, J=2.1 Hz), 3.40 (s, 3H, CH3). 13C-NMR
(CDCl3): l 129.0, 122.8, 119.4, 34.2.
References
3.3.3. 2-Bromo-N-methylbenzimidazole (4b)
M.p. 102–104°C (lit. [12]: 103–105°C). 1H-NMR
(CDCl3): l 7.72–7.65 (m, 1H, aromatics), 7.30–7.20
(m, 3H, aromatics), 3.75 (s, 3H, NCH3). 13C-NMR
(CDCl3): l 142.9, 136.0, 130.4, 123.2, 122.6, 119.2,
109.3, 31.7. MS (m/e): 212 [M++2], 210 [M+], 129,
104.
[1] (a) J.V. Metzger, Thiazoles and their benzoderivatives in: A.R.
Katrizky, C.W. Rees (Eds.), Comprehensive Heterocyclic Chem-
istry, vol. 6, Pergamon, New York, 1989, pp. 235–331. (b) M.R.
Grimmet, Imidazoles and their Benzoderivatives, vol. 5, Perga-
mon, New York, 1989, pp. 373–497. (c) L. Forlani, P.E.
Todesco, in: J.V. Metzger, A. Weissberger, E.C. Taylor (Eds.),
Thiazole and its Derivatives, Wiley, New York, 1979 (Chapter
5).
[2] (a) J.M. Sprague, A.H. Land, in: R.C. Edrefield, (Ed.), Hetero-
cyclic Compounds, vol. 5, Wiley, New York, 1957, pp. 537–542,
(Chapter 8). (b) J. Liebcher, Houben–Weyl, Methoden der
Organischen Chemie, Hetarene III, Part 2, vol. E8b, G. Thieme
Verlag, Stuttgart, 1994, p. 274.
[3] H.W. Gschwend, H.R. Rodriguez, Org. React. 26 (1979) 1.
[4] (a) K. Erlenmeyer, Helv. Chim. Acta 28 (1945) 985. (b) S.
Athmani, A. Bruce, B. Iddon, J. Chem. Soc. Perkin Trans. 1
(1992) 215. (c) A. Dondoni, A.R. Mastellari, A. Medici, E.
Negrini, P. Pedrini, Synthesis (1986) 757.
[5] (a) M. El Borai, A.H. Moustafa, M. Anwar, F.I. Abdel Hay Pol,
J. Chem. 55 (1981) 1659. (b) M.S. Shvartsberg, L.N. Bizhan, I.L.
Kotlyarevski, Bull. Acad. Sci. USSR Div. Chem. Sci. (Engl.
Transl.) 20 (1971) 1429. (c) M.S. Shvartsberg, L.N. Bizhan, A.N.
Sinyakov, R.N. Myasnikova, Bull. Acad. Sci. USSR Div. Chem.
Sci. (Engl. Transl.) 28 (1979) 1446. (d) A.N. Sinyakov, M.S.
Shvartsberg, Bull. Acad. Sci. USSR Div. Chem. Sci. (Engl.
Transl.) 28 (1979) 2128.
3.3.4. 2-(Dibromomethyl)-N-methylbenzimidazole (5)
1H-NMR (CDCl3): l 7.80–7.72 (m, 1H, aromatics),
7.39–7.31 (m, 3H, aromatics), 6.96 (s, 1H, CHBr2),
4.05 (s, 3H, NCH3). 13C-NMR (CDCl3): l 148.5, 139.6,
136.7, 124.7, 123.6, 120.5, 109.7, 31.6, 27.9. MS (m/e):
304 [M++2], 302 [M+], 225, 223, 212, 210, 129.
HRMS: C9H8Br2N2 requires: 301.9054. Found:
301.9049.
3.3.5. 5-Bromo-2-chlorothiazole (6)
A solution of 2-chlorothiazole 1c (0.18 g, 1.48 mmol,
in 5 ml of THF) was cooled at −70°C. After 15 min,
a 2.5 M solution of n-BuLi (0.6 ml, 1.48 mmol) in
n-hexane, diluted with 2 ml of anhydrous THF, was